Pharmacodynamic analysis of apremilast in Japanese patients with moderate to severe psoriasis: Results from a phase 2b randomized trial

We evaluated the pharmacodynamic effects of apremilast in 69 patients who were included in biomarker subanalyses of a phase 2b study that demonstrated the long‐term safety and efficacy of apremilast in Japanese adults with moderate to severe psoriasis. The association between cytokine levels and Pso...

Descripción completa

Detalles Bibliográficos
Autores principales: Imafuku, Shinichi, Nemoto, Osamu, Okubo, Yukari, Komine, Mayumi, Schafer, Peter, Petric, Rosemary, Ohtsuki, Mamitaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Concise Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821327/
https://www.ncbi.nlm.nih.gov/pubmed/32909643
http://dx.doi.org/10.1111/1346-8138.15596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821327/
https://www.ncbi.nlm.nih.gov/pubmed/32909643
http://dx.doi.org/10.1111/1346-8138.15596

Ejemplares similares